Skip to main content

Table 1 Measurements at baseline and during follow-up

From: Evaluating the impact of depression, anxiety & autonomic function on health related quality of life, vocational functioning and health care utilisation in acute coronary syndrome patients: the ADVENT study protocol

Outcome variable

Measurement tool/Data collection method

Time-point (months)

  

0

12

24

Primary outcome

    

 Difference in mean HRQoL (SF-36) Physical and Mental Health Summary scores at 12 and 24 month follow-up between the latent classes of depression and anxiety determined at baseline

Short Form 36 [47]

Secondary outcomes

    

Medical history

    

  Co-morbidities

Medical records

  

  Medications

Self-report discharge scripts

Clinical indicators

    

  Serum lipids; HbA1c; FBG; hs-CRP

Medical records

  

  Blood pressure; pulse

Clinical assessment

  Waist circumference

Clinical assessment

  Body Mass Index

Clinical assessment

  Diabetes

Self-report diagnosis; HbA1c

  Heart Rate Variability

Clinical assessment

Depression/anxiety

    

  Current depressive symptoms

BDI-II [40] & CDS [42]

  Current anxiety symptoms

STAI-S & STAI-T [43]

  Phobic Anxiety

Crown Crisp Index[45]

  Depression/anxiety history

CIDI- Auto 2.1 [50]

Behavioural measures

    

  Worry

The Penn State Worry Short Form [48]

  Sleep

Insomnia Severity Index [49]

  Work related outcomes

Self-report

Economic measures

    

  Preference-based measure of HRQoL (SF-6D)

Short Form 36 [47]

  Health care utilisation

Self-report